Skip to content

Cutting down unneeded antibiotics for HIV patients in Mozambique

De-implementation strategy to reduce unnecessary antibiotic prescriptions for ambulatory HIV-infected patients with upper respiratory tract infections in Mozambique: a study protocol of a cluster randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88272350
Enrollment
422
Registered
2024-05-16
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

De-implementation of antibiotic use among ambulatory HIV-infected adults with upper respiratory tract infection Infections and Infestations

Interventions

A multicenter two-arm cluster randomized controlled implementation science trial will be undertaken employing a mixed-methods approach. This study will be guided by two conceptual frameworks, the Dyna

Sponsors

Tulane University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Adult HIV-infected patients with URTI symptoms 2. Frontline healthcare workers in selected primary healthcare clinics providing HIV care and treatment services

Exclusion criteria

Exclusion criteria: 1. Adult HIV-infected patients without URTI symptoms 2. Fever =39ºC 3. Severe mental illness 4. Advanced HIV status

Design outcomes

Primary

MeasureTime frame
Appropriate non-prescription of antibiotics for upper respiratory tract infection measured using study data collected on a registration form on the day of a medical visit and 5 or 10 days after the initial visit if not recovered

Secondary

MeasureTime frame
1. The proportion of clinicians who adopted the de-implementation strategy measured using study data collected on the registration form on the day of a medical visit and 5 or 10 days after the initial visit if not recovered 2. Clinician satisfaction with the use of the clinical decision support algorithm measured using an in-depth interview record and a 5-point Likert scale at 6 months of the intervention period (the end of the intervention phase) 3. Fidelity to the de-implementation strategy measured using study data collected on the registration form at the end of the intervention phase 4. Feasibility of use of the clinical decision support algorithm measured using study data collected on the registration form and in-depth interview records at the end of the intervention phase

Countries

Mozambique

Contacts

Public ContactCandido Faiela
candido.faiela@gmail.com+258 847145631

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 11, 2026